Innate Pharma (IPHA) Enterprise Value Growth (1y) (2018 - 2025)
Innate Pharma (IPHA) Enterprise Value Growth (1y) (2018 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
| 10 |
Innate Pharma |
194.19 Mn |
194.19 Mn |
- |
| Date | Value |
|---|
| Dec 31, 2025 |
53.73% |
| Jun 30, 2025 |
31.72% |
| Dec 31, 2024 |
13.24% |
| Jun 30, 2024 |
10.14% |
| Dec 31, 2023 |
3.92% |
| Jun 30, 2023 |
16.41% |
| Dec 31, 2022 |
24.47% |
| Jun 30, 2022 |
27.69% |
| Dec 31, 2021 |
24.17% |
| Jun 30, 2021 |
99.88% |
| Dec 31, 2020 |
25.37% |
| Jun 30, 2020 |
-86,224.56% |
| Dec 31, 2019 |
-26.69% |
| Dec 31, 2018 |
-39.87% |
